13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001193125-25-283054
Total Value
$164.2M
Positions
25
Other Managers
1
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SOLENO THERAPEUTICS INC | SLNO | 302,483 | $20.4M | 12.45% |
| 2 | SOLENO THERAPEUTICS INC | SLNO | 250,000 | $16.9M | 10.29% |
| 3 | MADRIGAL PHARMACEUTICALS INC | MDGL | 32,662 | $15.0M | 9.12% |
| 4 | ATAI BECKLEY NV | N0731H103 | 2,287,005 | $12.1M | 7.37% |
| 5 | ASCENDIS PHARMA A/S - ADR | ASND | 51,080 | $10.2M | 6.18% |
| 6 | LENZ THERAPEUTICS INC | LENZ | 175,363 | $8.2M | 4.97% |
| 7 | REPLIMUNE GROUP INC | REPL | 1,850,000 | $7.8M | 4.72% |
| 8 | REPLIMUNE GROUP INC | REPL | 1,750,000 | $7.3M | 4.47% |
| 9 | COMPASS PATHWAYS PLC | CMPS | 1,145,700 | $6.6M | 4.00% |
| 10 | TAYSHA GENE THERAPIES INC | TSHA | 1,898,112 | $6.2M | 3.78% |
| 11 | AMYLYX PHARMACEUTICALS INC | AMLX | 437,391 | $5.9M | 3.62% |
| 12 | COMPASS PATHWAYS PLC | CMPS | 1,026,382 | $5.9M | 3.58% |
| 13 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 915,000 | $5.4M | 3.29% |
| 14 | PRAXIS PRECISION MEDICINES I | PRAX | 100,000 | $5.3M | 3.23% |
| 15 | MONOPAR THERAPEUTICS INC | MNPR | 64,455 | $5.3M | 3.21% |
| 16 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 233,220 | $4.4M | 2.68% |
| 17 | MIND MEDICINE MINDMED INC | 60255C885 | 361,444 | $4.3M | 2.60% |
| 18 | TARSUS PHARMACEUTICALS INC | TARS | 70,778 | $4.2M | 2.56% |
| 19 | SOLID BIOSCIENCES INC | SLDB | 549,182 | $3.4M | 2.06% |
| 20 | PROMIS NEUROSCIENCES INC | PMN | 6,233,497 | $2.6M | 1.61% |
| 21 | AVALO THERAPEUTICS INC | AVTX | 178,100 | $2.3M | 1.38% |
| 22 | TECTONIC THERAPEUTIC INC | TECX | 138,595 | $2.2M | 1.32% |
| 23 | WHITEHAWK THERAPEUTICS INC | WHWK | 817,939 | $1.6M | 0.95% |
| 24 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 69,000 | $494,730 | 0.30% |
| 25 | ATYR PHARMA INC | ATYR | 600,000 | $432,840 | 0.26% |